Outcomes of Transplantation with Related- and Unrelated-Donor Stem Cells in Children with Severe Thalassemia

This publication has 13 references indexed in Scilit:

• Nonmyeloablative stem cell transplantation with a haploidentical donor in a class 3 lucarelli severe thalassemia patient
  Bone Marrow Transplantation, 2004
• Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells
  The Lancet, 2004
• Outcome of transplantation with unrelated donor bone marrow in children with severe thalassaemia
  Bone Marrow Transplantation, 2003
• Cytomegalovirus in hematopoietic stem cell transplant recipients: current status, known challenges, and future strategies
  Transplantation and Cellular Therapy, 2003
• Full chimerism in nonmyeloablative stem cell transplantation in a β-thalassemia major patient (class 3 Lucarelli)
  Bone Marrow Transplantation, 2002
• Unrelated donor bone marrow transplantation for thalassemia: the effect of extended haplotypes
  Blood, 2002
• Treatment of severe steroid refractory acute graft-versus-host disease with infliximab, a chimeric human/mouse antiTNFα antibody
  Bone Marrow Transplantation, 2001
• Treatment of steroid refractory acute and chronic graft‐versus‐host disease with daclizumab
  British Journal of Haematology, 2001
• MARROW TRANSPLANTATION FROM UNRELATED VOLUNTEER DONORS
  Annual Review of Medicine, 1995
• EFFICACY OF A SHORT COURSE (FOUR DOSES) OF METHOTREXATE FOLLOWING BONE MARROW TRANSPLANTATION FOR PREVENTION OF GRAFT-VERSUS-HOST DISEASE
  Transplantation, 1985